|
|
|
Market Research Report
Top 10 Medical Device Technology
| Published by |
Markets and Markets |
| Published |
September, 2009 |
Product code |
99911 |
| Content info |
210 pages |
| Price |
|
|
Top 10 Medical Device Technology published by Markets and Markets in September, 2009. This report consists of 210 pages and the price starts from US $ 4650.
Abstract
Report description
Technological innovations in the medical device industry have led to a radical
transformation in patient care. This report identifies the sectors with the
industry' s most important developments related to patient care, clinical
outcomes, and new product development. While the scope of the report is
limited to the top ten technologies only, it covers almost the entire medical
device market.
Scientific and medical technology breakthroughs - such as minimally invasive
surgery (MIS) - have accelerated the accuracy of clinical outcomes and have
also reduced recovery times and the medical costs borne by patients. This has
led to radical transformation in patient care.
IT integration in medical imaging and medical devices has given a significant
boost to the healthcare industry, a trend that is apparent in the market
growth of drug eluting stents and telemedicine technologies. The markets
covered in the report have a current potential of $454.3 billion and are
expected to grow at a CAGR of 9.8% between 2009 and 2014.
Market estimates and forecast
The report provides in-depth market estimates and forecast for top ten medical device technologies as follows:
- Diagnostic imaging (nuclear imaging, interventional radiology, capsule
endoscopy and others)
- Drug delivery (needle free injections, transdermal systems, inhalation
system, infusion system)
- Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)
- Mobility aid technologies
- Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics
and others)
- Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips,
protein chips)
- Non-invasive monitoring (continuous blood glucose monitoring)
- Biomaterials (bionic limbs, joint replacement, antimicrobial wound
dressing and others)
- Bio-implants (neurostimulation and others)
- Tele-medicines
Each section will provide market data, market drivers, trends and
opportunities, top-selling products, key players, and competitive outlook.
This report will also provide more than 100 market tables for various
geographic regions covering the sub-segments and micro-markets. In addition,
the report also provides 50 company profiles for each of its sub-segments.
What makes our reports unique?
- We provide the longest market segmentation chain in this industry- not
many reports provide market breakdown upto level 5.
- Each report is about 250 pages with 100+ market data tables, 40
competitive company profiles, analysis of 300 patents and minimum 50 micro
markets, which are collectively exhaustive and mutually exclusive.
- No single report by any other publisher provides market data for all the
segments viz products, services, applications, ingredients, technology, and
stakeholders in a single report for all the four geographies - US, Europe,
APAC, ROW.
- We provide 10% customization - Research shows that more than 40% of the
times, clients do not get the specific intelligence they need in multi-client
market research reports. We offer 10% customization in our reports at no extra
cost. Get the exact market intelligence you require with real value for money.
- 15 pages of high level analysis including benchmarking strategies, best
practices and the market' s cash cows (BCG matrix). We conduct detailed market
positioning, product positioning and competitive positioning. Entry
strategies, gaps and opportunities are identified for all the stakeholders.
- Comprehensive market analysis for pharmaceutical and biotech companies,
medical device manufacturers, pharma-research labs, doctors, physicians and
hospitals, medical/pharma associations, retailers and super-retailers,
technology providers, and research and development (R&D) companies.
Key questions answered
- Which are the high-growth segments/cash cows and how is the market
segmented in terms of applications, products, services, ingredients,
technologies, and stakeholders?
- What are market estimates and forecasts; which markets are doing well and
which are not?
- Where are the gaps and opportunities; what is driving the market?
- Which are the key playing fields? Which are the winning edge imperatives?
- How is the competitive outlook; who are the main players in each of the
segments; what are the key selling products; what are their strategic
directives, operational strengths and product pipelines? Who is doing what?
Powerful Research and Analysis
The analysts working with MarketsandMarkets come from renowned publishers and
market research firms, globally, adding their expertise and domain
understanding. We get the facts from over 22,000 news and information sources,
a huge database of key industry participants and draw on our relationships
with more than 900 market research companies across the world. We, at
MarketsandMarkets, are inspired to help our clients grow by providing
qualitative business insights with our huge market intelligence repository.
Table of Contents
1. INTRODUCTION
- 1.1. KEY TAKE AWAYS
- 1.2. REPORT DESCRIPTION
- 1.3. MARKETS COVERED
- 1.4. STAKEHOLDERS
- 1.4.1.MEDICAL DEVICE MANUFACTURERS
- 1.4.2.HOSPITAL SURGICAL DEPARTMENTS
- 1.4.3.CLINICAL RESEARCH FIRMS
- 1.4.4.BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS
2. SUMMARY
3. MARKET OVERVIEW
- 3.1. COMPARATIVE ANALYSIS OF THE TOP TEN MEDICAL DEVICE TECHNOLOGIES
- 3.2. EVOLUTION OF MEDICAL DEVICE TECHNOLOGIES
- 3.3. DEFINING THE TOP TEN MEDICAL DEVICE TECHNOLOGIES MARKET
- 3.4. PHYSICIANS ADOPTING INNOVATIVE TECHNOLOGIES
- 3.5. AGING POPULATION DRIVES THE MARKET
- 3.5.1. OPPORTUNITY LIES IN LESS DEVELOPED COUNTRIES
- 3.6. SYNERGY BETWEEN TECHNOLOGIES GIVES BETTER OUTCOMES
- 3.7. PRODUCT RECALLS ARE A MAJOR CHALLENGE
4. DIAGNOSTIC IMAGING
- 4.1. DRIVERS
- 4.1.1. EMERGENCE OF NEW TECHNOLOGY
- 4.1.2. WIDE APPLICATION AREAS
- 4.1.3. AGING DEMOGRAPHICS
- 4.1.4. FOCUS ON PREVENTIVE HEALTHCARE
- 4.1.5. CMS COVERS MORE TESTS
- 4.2. RESTRAINTS
- 4.2.1. ECONOMIC SLOWDOWN
- 4.2.2. REGULATORY BODIES RAISE HEALTHCARE COSTS
- 4.3. COMPETITIVE LANDSCAPE
- 4.4. MRI SYSTEMS
- 4.4.1. DRIVERS
- 4.4.1.1. Wide Range of Applications
- 4.4.1.2. Improvement in Telsa Strength
- 4.4.2. COMPETITIVE LANDSCAPE
- 4.5. ULTRASOUND SYSTEMS
- 4.5.1. DRIVERS
- 4.5.1.1.Untapped Demand in Emerging Markets
- 4.5.1.2.Booming Refurbished Equipment Market for Ultrasound Systems
- 4.5.1.3.Increased Use of Ultrasound by EMS
- 4.5.2. RESTRAINTS
- 4.5.2.1. Saturation in Core Markets
- 4.5.2.2. Lack of Clear Reimbursement Policies
- 4.5.3. COMPETITIVE LANDSCAPE
- 4.6. X-RAY SYSTEMS
- 4.6.1. DRIVERS
- 4.6.1.1. Fine Image Quality
- 4.6.2. RESTRAINTS
- 4.6.2.1. Other advanced technologies hindering growth of X-ray market
- 4.6.2.2. High degree of Competition
- 4.6.3. COMPETITIVE LANDSCAPE
- 4.6.3.1. Mergers and Acquisitions
- 4.6.3.2. New X-ray Systems
- 4.7. MAMMOGRAPHY EQUIPMENT
- 4.7.1. DRIVERS
- 4.7.1.1. Increase in Demand
- 4.7.1.2. Favorable Reimbursement Scenario
- 4.8. TOMOGRAPHY EQUIPMENT
- 4.8.1. DRIVERS
- 4.8.1.1. Introduction of Higher Slice CT Scanner
- 4.8.1.2. Increase in Angiogram CT Application
- 4.8.1.3. Introduction of OCT
- 4.8.2. RESTRAINTS
- 4.8.2.1. Shift from a Slice Count Basis to Detector Coverage
- 4.8.2.2. MRI Moving Ahead of CT Scan
- 4.8.3. COMPETITIVE DEVELOPMENT
- 4.9. NUCLEAR IMAGING EQUIPMENT
- 4.9.1. COMPETITIVE LANDSCAPE
- 4.9.1.1. Other Developments
- 4.10. INTERVENTIONAL RADIOLOGY
- 4.10.1. DRIVERS
- 4.10.1.1. Advances in Medical Instrumentation and Radiological Imaging
Technology
- 4.10.1.2. Minimally Invasive Imaging Procedures Gaining Popularity
- 4.10.2. RESTRAINTS
- 4.10.2.1. Financial Limitation Hinders Capital Investment
- 4.10.2.2. Lack of Professional Radiologists
- 4.11. CAPSULE ENDOSCOPY
- 4.11.1. DRIVERS
- 4.11.1.1. Increased Application of Capsule Endoscopy
- 4.11.1.2. FDA Clearances
- 4.11.2. COMPETITIVE LANDSCAPE
- 4.12. LASERS - IMAGING
- 4.12.1. DRIVERS
- 4.12.1.1. Reasonable Pricing
- 4.12.1.2. Expansion of scope and opportunities for laser technology
5. DRUG DELIVERY DEVICES
- 5.1. INHALATION SYSTEMS
- 5.2. COMPETITIVE LANDSCAPE
- 5.3. INFUSION SYSTEMS
- 5.3.1. COMPETITIVE LANDSCAPE
- 5.4. NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS
- 5.5. INCREASE IN INCIDENCE OF ARTHRITIS AND HORMONE DEFICIENCY
- 5.6. OTHER DEVELOPMENTS IN NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET
6. MEDICAL DIAGNOSTICS
- 6.1. DRIVERS
- 6.1.1. POPULARITY OF HOME HEALTHCARE 66
- 6.1.2. DEMAND FOR GENETIC, MOLECULAR DIAGNOSTIC TESTING
- 6.2. RESTRAINTS
- 6.2.1. ECONOMIC SLOWDOWN AND INSURANCE ISSUES
- 6.3. BIOSENSORS
- 6.3.1. DRIVERS
- 6.3.1.1. Increase in Biosensor Usage Due To Multiple Applications
- 6.3.1.2. Unhealthy Lifestyles
- 6.3.1.3. Miniaturization Key to Success of Biosensors
- 6.3.2. RESTRAINTS
- 6.4. IN VITRO DIAGNOSTIC (IVD)
- 6.4.1. DRIVERS
- 6.4.1.1. Demand for IVD in Emerging Markets
- 6.4.1.2. Increasing Need For Diagnostic Services
- 6.4.1.3. Increasing Accessibility of Healthcare Services
- 6.4.2. RESTRAINTS
- 6.4.2.1. Consolidation of Hospital and Commercial Laboratories
- 6.4.2.2. Intense FDA Scrutiny on IVD Diagnostic Market
- 6.5. PROTEOMICS FOR MEDICAL DIAGNOSTICS
- 6.5.1. DRIVERS
- 6.5.1.1. Proteomics Targeting More Diseases
- 6.5.1.2. Enables Pharmacological Profiling, Toxicity Testing
- 6.5.1.3. Detection of Non-communicable Diseases
- 6.5.2. RESTRAINTS
- 6.5.2.1. Protein Structuring Needs Expensive Instrumentation
- 6.5.2.2. Cost and Reimbursement Issues
- 6.5.2.3. Lack of Technologies to Speed up Validation Process
- 6.6. NANOTECHNOLOGY FOR MEDICAL DIAGNOSTICS
- 6.6.1. DRIVERS
- 6.6.1.1. Increase in Demand for Genetic & Preimplantation Screening
- 6.6.2. OPPORTUNITY
- 6.6.2.1. Nanotechnology for Cancer Diagnostics
- 6.6.3. RESTRAINT
- 6.6.3.1. Lack of Commercialization
- 6.6.3.2. Other Developments
- 6.7. POLYMERASE CHAIN REACTION (PCR)
- 6.7.1. DRIVERS
- 6.7.1.1. Potential to Replace Conventional Tests for Diseases
- 6.7.1.2. FDA Clearance for Real-Time PCR Instrumentation
- 6.7.2. RESTRAINTS
- 6.7.2.1. qPCR Technology Replacing Conventional PCR
- 6.7.2.2. Price sensitivity of PCR technology
- 6.8. ARRAYS
- 6.8.1. DRIVERS
- 6.8.1.1. Demand for Protein Array on Rise
- 6.8.1.2. Micro Array Technology Classifies Cancers
- 6.8.1.3. Minimal Use of Materials Makes Microarrays an Inexpensive
Technology
7. MOBILITY AID TECHNOLOGIES
- 7.1. DRIVERS
- 7.1.1. POPULATION WITH MOBILITY ISSUES 81
- 7.1.2. SPORTS FOR PHYSICALLY CHALLENGED GAINING POPULARITY
- 7.1.3. EMERGENCE OF ROBOTICS TECHNOLOGY
- 7.2. COMPETITIVE LANDSCAPE
- 7.3. GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY PRODUCTS
- 7.3.1. WHEELCHAIRS AND RELATED DEVICES
- 7.3.1.1. Drivers
- 7.3.1.1.1. Wide Range of Designs, Materials, and Configurations
- 7.3.1.1.2. Increase in Demand for Power Wheelchair
- 7.3.1.2. Restraints
- 7.3.1.2.1. Power Dependence
- 7.3.1.2.2. Powered Assist Devices are Costly and Less Portable
- 7.3.1.2.3. Reimbursement Issues with Powered Wheelchairs
- 7.3.1.3. Competitive Landscape
- 7.3.2. WALKING-ASSIST DEVICES
- 7.4. GLOBAL MOBILITY AID DEVICE MARKET BY TECHNOLOGY
- 7.4.1. ROBOTICS
- 7.4.2. NON-ROBOTICS
8. MINIMAL INVASIVE/NON-INVASIVE SURGERY
- 8.1. DRIVERS
- 8.1.1. LESS PAINFUL AND SHORT CONVALESCENCE
- 8.1.2. INCREASED NEED OF SURGERIES FOR THE ELDERLY
- 8.1.3. HIGHER RATE OF ACCEPTANCE
- 8.2. RESTRAINTS
- 8.2.1. LIMITED NUMBER OF SURGERIES PERFORMED
- 8.2.2. SPECIAL TRAINING AND EQUIPMENT REQUIRED
- 8.3. OPPORTUNITIES
- 8.4. STENT
- 8.4.1. DRIVERS
- 8.4.1.1. Rise in Cardiovascular Diseases
- 8.4.1.2. Increasing Incidence of Obesity and Diabetes
- 8.5. MEDICAL ROBOTICS
- 8.5.1. DRIVERS
- 8.5.1.1. Improved Surgical Results
- 8.5.1.2. Hospitals encourage medical robots
- 8.5.1.3. Cost effectiveness
- 8.5.2. COMPETITIVE LANDSCAPE
- 8.6. LASERS
- 8.6.1. DRIVERS
- 8.6.1.1. Growing Awareness
- 8.6.1.2. Rise in Age-Related Diseases
- 8.6.2. DEVELOPMENTS
- 8.7. BARIATRIC SURGERY
- 8.7.1. DRIVERS
- 8.7.1.1. Increasing Incidence of Weight Problems
- 8.7.1.2. Technological Innovation
- 8.7.1.3. Rising Obesity among Children
9. MICRO- FLUIDS CHIP AND MEMS
- 9.1. DRIVERS
- 9.1.1. COST-EFFECTIVE COMPLEX ANALYSIS SYSTEM
- 9.1.2. ESSENTIAL TOOL FOR MASS SPECTROMETRY
- 9.1.3. COMPLETE AUTOMATION IN A SINGLE DEVICE
- 9.1.4. GREATER SPEED & HIGHER QUALITY
- 9.1.5. MINIMAL REQUIREMENT OF SAMPLES REDUCES COST
- 9.2. RESTRAINTS
- 9.2.1. MICROFLUIDIC CHIP TECHNOLOGY CANNOT MIX FLUIDS
- 9.2.2. LACK OF COMMERCIALIZATION
- 9.3. MINIATURE MEDICAL PRESSURE SENSORS
- 9.4. BIOCHIPS
- 9.4.1. DRIVERS AND RESTRAINTS
- 9.4.1.1. Application of biochips in personalized medicine
- 9.4.1.2. Biochips help save time
- 9.4.1.3. Biochips aid new drug discovery
- 9.4.1.4. High cost associated with biochips
- 9.5. COMPETITIVE LANDSCAPE
- 9.5.1. Other developments
- 9.5.2. LAB CHIPS
- 9.5.3. PROTEIN CHIPS
10.NON-INVASIVE MONITORING
- 10.1.BIOSENSORS
- 10.1.1. WIDE SCALE ACCEPTABILITY OF BIOSENSORS
- 10.1.2. HIGH COST INVOLVED IN COMMERCIALIZATION
- 10.1.3. CONTINUOUS GLUCOSE MONITORING
- 10.1.3.1. Drivers
- 10.1.3.1.1. Increasing incidence of diabetes
- 10.1.3.1.2. Convenience of non-invasive continuous glucose monitoring
11.BIOMATERIALS
- 11.1.INCREASE IN ORTHOPEDIC PROBLEMS
- 11.2.HIGH DEGREE OF REGULATORY SCRUTINY
- 11.3.APPLICATIONS OF BIOMATERIALS
- 11.4.BIONIC LIMBS
- 11.4.1. COMPETITIVE LANDSCAPE
- 11.5.BIO-COMPATIBLE MATERIALS
- 11.5.1. DRIVERS
- 11.5.1.1. Advancements in nanotechnology
- 11.5.1.2. Increase in demand of bio-compatible materials
- 11.5.2. VULCANIZED SILICON-BASED MATERIALS
- 11.5.3. JOINT REPLACEMENT
- 11.5.3.1. Drivers
- 11.5.3.1.1. Increasing acceptability of bone grafts substitutes
- 11.5.3.2. Restraints
- 11.5.3.2.1. Rise in prices of titanium
- 11.5.3.2.2. Modification in reimbursement policies
- 11.6.ANTIMICROBIAL WOUND DRESSING
- 11.6.1. DRIVERS
- 11.6.1.1.1. New products in anti-microbial wound dressing
- 11.6.1.1.2. Increasing demand in the home healthcare sector
12.BIO-IMPLANTS
- 12.1.GRAFT-BASED IMPLANTS
- 12.1.1. DRIVERS
- 12.1.1.1. Increasing medical acceptance of graft-based implants
- 12.1.1.2. Increasing popularity of cosmetic surgery
- 12.1.2. RESTRAINTS
- 12.1.2.1. Expensive bone grafts
- 12.2.SYNTHETIC IMPLANTS
- 12.2.1. DRIVERS
- 12.2.1.1. Wide range of applications
- 12.2.1.2. Synthetic implants are bio-compatible
- 12.2.2. NEUROSTIMULATION
- 12.2.2.1. Drivers
- 12.2.2.1.1. Increase in neurological disorders
- 12.2.2.1.2. Increase in demand for less complicated operating methods
- 12.2.2.1.3. Short treatment period
- 12.2.2.1.4. Technological advancements
- 12.2.2.2.5 The use of implantable neurostimulation devices
- 12.2.2.2. Opportunities
- 12.2.2.2.1. Wide range of innovative therapies
- 12.2.2.2.2. Huge market size encourages market growth
- 12.2.2.3. Spinal Cord Stimulation (SCS)
- 12.2.2.3.1. Drivers
- 12.2.2.3.1.1. Wide range of applications of spinal cord devices
- 12.2.2.3.1.2. New improved technology in spinal cord stimulator
devices
- 12.2.2.3.2. Opportunities
- 12.2.2.3.2.1. FDA approval for spinal cord stimulator devices
- 12.2.2.4. Developments
- 12.2.2.5. Sacral Nerve Stimulation (SNS)
- 12.2.2.5.1. Drivers
- 12.2.2.5.1.1. Rise in number of patients
- 12.2.2.5.1.2. Sacral stimulation treatments facilitate increased
surgical accuracy
- 12.2.2.5.2. Opportunities
- 12.2.2.5.2.1. Huge potential in Asian countries
- 12.2.2.6. Vagus Nerve Stimulation (VNS)
- 12.2.2.6.1. Drivers
- 12.2.2.6.1.1. Effective treatment for partial -onset seizures
- 12.2.2.6.2. Opportunities
- 12.2.2.6.2.1. Developments for VNS Market
- 12.2.2.6.2.2. Regulatory Approval for VNS Market
- 12.2.2.7. Deep Brain Stimulation Systems
- 12.2.2.7.1. Drivers
- 12.2.2.7.1.1. Improved treatments results attracting more patients
- 12.2.2.7.1.2. New and advanced technology provides greater
flexibility to neurosurgeons
- 12.2.2.7.2. Restraints and Opportunities
- 12.2.2.7.3. Competitive Landscape
13.TELEMEDICINE
- 13.1.DRIVERS
- 13.1.1. INCREASE IN INCIDENCE OF CHRONIC DISEASES
- 13.1.2. COMPLEXITY OF HEALTHCARE NETWORK
- 13.1.3. INCREASED IT EXPENDITURE
- 13.1.4. SHIFTING TREND FROM TREATMENT TO EARLY INTERVENTION
- 13.2.RESTRAINTS
- 13.2.1. UNCERTAIN REIMBURSEMENT FOR TELEMEDICINE
- 13.2.2. LACK OF FUNDING FOR TELEMEDICINE PROGRAMS
- 13.2.3. TELEMEDICINE TECHNOLOGY
- 13.2.3.1. Hardware
- 13.2.3.2. Software
- 13.2.3.3. Network and Telecom
- 13.2.3.3.1. Telecom and networking market
- 13.2.3.3.2. Telehome T&N market
- 13.2.3.3.3. Telehospital/clinics T&N market
14.TOP TEN MEDICAL DEVICE TECHNOLOGIES PATENT ANALYSIS
15.COMPANY PROFILES
- 15.1.ABBOTT LABORATORIES
- 15.1.1. OVERVIEW
- 15.1.2. DEVELOPMENTS
- 15.2.ATRIUM MEDICAL CORPORATION
- 15.2.1. OVERVIEW
- 15.2.2. DEVELOPMENTS
- 15.3.BOSTON SCIENTIFIC
- 15.3.1. OVERVIEW
- 15.3.2. DEVELOPMENTS
- 15.4.BERCHTOLD CORPORATION (SUBSIDIARY OF BERCHTOLD GMBH & CO. KG)
- 15.4.1. OVERVIEW & PRODUCTS
- 15.5.CONOR MEDSYSTEMS, LLC
- 15.5.1. OVERVIEW
- 15.5.2. DEVELOPMENTS
- 15.6.CELONOVA BIOSCIENCES INC
- 15.6.1. OVERVIEW
- 15.6.2. DEVELOPMENTS
- 15.7.ETHICON ENDO-SURGERY
- 15.7.1. OVERVIEW & DEVELOPMENTS
- 15.8.INTROMEDIC
- 15.8.1. OVERVIEW & PRODUCT
- 15.8.2. DEVELOPMENTS
- 15.9.HITACHI MEDICAL CORPORATION
- 15.9.1. OVERVIEW
- 15.9.2. DEVELOPMENTS
- 15.10.GIVEN IMAGING
- 15.10.1. OVERVIEW
- 15.10.2. DEVELOPMENTS
- 15.11. GE HEALTHCARE
- 15.11.1. OVERVIEW
- 15.11.2. DEVELOPMENTS
- 15.12.BIOMET, INC
- 15.12.1. OVERVIEW
- 15.12.2. DEVELOPMENTS
- 15.13.SIEMENS MEDICAL SOLUTIONS
- 15.13.1. OVERVIEW
- 15.13.2. DEVELOPMENTS
- 15.14.XTENT, INC.
- 15.14.1. OVERVIEW & PRODUCTS
- 15.15.VALLEYLAB
- 15.16.TERUMO MEDICAL CORPORATION
- 15.16.1. OVERVIEW
- 15.16.2. DEVELOPMENTS
- 15.17.MIV THERAPEUTICS, INC.
- 15.17.1. OVERVIEW
- 15.17.2. DEVELOPMENTS
- 15.18.ORBUSNEICH
- 15.18.1. OVERVIEW & DEVELOPMENTS
- 15.19.STENTYS S.A.S.
- 15.19.1. OVERVIEW & DEVELOPMENTS
- 15.20.MEDINOL LTD.
- 15.20.1. OVERVIEW
- 15.20.2. DEVELOPMENTS
- 15.21.PROSURGICS
- 15.21.1. OVERVIEW
- 15.21.2. DEVELOPMENTS
- 15.22.ROCHE
- 15.22.1. OVERVIEW
- 15.22.2. R&D INNOVATIONS
- 15.23.OLYMPUS
- 15.23.1. OVERVIEW
- 15.23.2. DEVELOPMENTS
- 15.24.MEDTRONIC, INC.
- 15.24.1. OVERVIEW
- 15.24.2. DEVELOPMENTS
- 15.25.SCIENTIFIC INTAKE CO LTD
- 15.26.SATIETY, INC
- 15.27.METACURE NV
- 15.28.LEPTOS BIOMEDICAL, INC.
- 15.29.SMITH & NEPHEW
- 15.29.1. OVERVIEW
- 15.29.2. DEVELOPMENTS
- 15.30.ENDOART SA
- 15.31.INTUITIVE SURGICAL, INC
- 15.31.1. PRODUCTS
- 15.31.2. DEVELOPMENTS
- 15.32.ALLERGAN
- 15.33.ENTEROMEDICS
- 15.33.1. OVERVIEW & PRODUCTS
- 15.34.HÉLIOSCOPIE SA
- 15.35.KARL-STORZ GMBH & CO. KG
- 15.35.1. RECENT DEVELOPMENTS
- 15.36.BARONOVA, INC.
- 15.36.1. OVERVIEW & PRODUCTS
- 15.37.ESAOTE SPA
- 15.37.1. OVERVIEW
- 15.37.2. DEVELOPMENTS
- 15.38.STRYKER
- 15.38.1. OVERVIEW
- 15.38.2. EVELOPMENTS
APPENDIX
|
 |
